The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes

被引：0
|
作者：
Sohn, S. K. [1 ]
Moon, J. H. [1 ]
Lee, Y. J. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Kim, Y. K. [1 ]
Suh, J. S. [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Keimyung Univ, Dongsan Hosp, Taegu, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [1] The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes.
    Sohn, Sang Kyun
    Lee, Soo Jung
    Kim, Jong Gwang
    Chae, Yee Soo
    Kang, Byung Woog
    Moon, Joon Ho
    Baek, Jin Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
    Moon, Joon Ho
    Lee, Yoo Jin
    Seo, Sang Kyung
    Han, Seo Ae
    Yoon, Joon Seok
    Ham, Ji Yeon
    Suh, Jang Soo
    Sohn, Sang Kyun
    ACTA HAEMATOLOGICA, 2015, 133 (04) : 327 - 335
  • [3] Monosomal Karyotype Predicts Survival In Patients with High Risk AML Undergoing Allogeneic Stem Cell Transplantation
    Middeke, Jan Moritz
    Beelen, Dietrich
    Stadler, Michael
    Baurmann, Herrad
    Bug, Gesine
    Bellos, Frauke
    Mohr, Brigitte
    Birninger, Nicole
    Buchholz, Stefanie
    Schwerdtfeger, Rainer
    Martin, Hans
    Hegenbart, Ute
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schetelig, Johannes
    BLOOD, 2010, 116 (21) : 1133 - 1134
  • [4] Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients
    Oran, Betul
    Dolan, Michelle
    Ma, Linan
    Brunstein, Claudio
    Warlick, Erica
    Weisdorf, Daniel J.
    BLOOD, 2009, 114 (22) : 218 - 219
  • [5] Indications for allogeneic stem cell transplantation in patients with AML
    Passweg, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 227 - 227
  • [6] Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
    Hobbs, Gabriela Soriano
    Perales, Miguel-Angel
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (03): : 488 - 503
  • [7] Does Allogeneic Hematopoietic Cell Transplantation Benefit Older (≥ 60) AML/MDS Patients With Monosomal Karyotype?
    Slack, James L.
    Khera, Nandita
    Fauble, Veena
    Leis, Jose F.
    Sproat, Lisa
    Klein, Jared
    Reeder, Craig B.
    Betcher, Jeffrey A.
    Noel, Pierre
    BLOOD, 2013, 122 (21)
  • [8] IMPACT OF MONOSOMAL KARYOTYPE ON THE OUTCOMES OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION FOR OLDER PATIENTS (>60 YEARS OF AGE) WITH AML/MDS
    Leis, J.
    Khera, N.
    Fauble, V.
    Sproat, L.
    Reeder, C.
    Betcher, J.
    Noel, P.
    Slack, J.
    HAEMATOLOGICA, 2014, 99 : 171 - 171
  • [9] Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML- A strong case for allogeneic stem cell transplantation in first complete remission
    Stahl, Maximilian
    Tallman, Martin S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 806 - 808
  • [10] Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype
    Wudhikarn, Kitsada
    Van Rheeden, Richard
    Leopold, Christina
    Rattanaumpawan, Pinyo
    Gingrich, Roger
    Silverman, Margarida de Magalhaes
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (04) : 294 - 301
12345